Who owns OPKO HEALTH, INC. (OPK)? Elite investor 13F holders

3 tracked elite investors reported holding OPKO HEALTH, INC as of 2026-09-30, including Rubric Capital, Renaissance Technologies LLC, GAMCO. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

3 tracked investors currently reported holding · Latest report period: 2026-09-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
Rubric CapitalOPKO HEALTH INCSHARE2026-09-302026-11-16 00:00:0076943901.00 USD47791243.000000SharesholdOriginal filing
Rubric CapitalOPKO HEALTH INCSHARE2026-09-302026-11-16 00:00:001957098.00 USD1250000.000000PrincipalholdOriginal filing
Renaissance Technologies LLCOPKO HEALTH INCSHARE2026-09-302026-11-12 00:00:001628061.00 USD1011218.000000SharesbuyOriginal filing
GAMCOOPKO HEALTH INCSHARE2026-09-302026-11-12 00:00:00281750.00 USD175000.000000SharesholdOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown